Insulin Lispro
- Generic Name
- Insulin Lispro
- Brand Names
- Admelog, Humalog, Humalog Mix, Humalog kwikpen, Liprolog, Lyumjev, Insulin lispro Sanofi, Lyumjev (previously Liumjev)
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 133107-64-9
- Unique Ingredient Identifier
- GFX7QIS1II
- Background
Insulin lispro is a rapid-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin is release...
- Indication
本品尤其适用于下列情况：
1.经常发生低血糖的1型糖尿病者，使用本品可减少低血糖的发生率；
2.生活不规律，外出活动较多的用胰岛素治疗的糖尿病患者，本品快速、短效的特点有助于及时调整胰岛素的用量。
- Associated Conditions
- Diabetes Mellitus, Diabetic Ketoacidosis, Gestational Diabetes Mellitus (GDM)
- Associated Therapies
- -
Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2014-02-26
- Lead Sponsor
- Medical University of Graz
- Target Recruit Count
- 20
- Registration Number
- NCT01792323
- Locations
- 🇦🇹
Medical University of Graz, Graz, Styria, Austria
A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2018-04-20
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 212
- Registration Number
- NCT01792284
- Locations
- 🇵🇷
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bayamon, Puerto Rico
Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
- Conditions
- Interventions
- First Posted Date
- 2012-08-13
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Sansum Diabetes Research Institute
- Target Recruit Count
- 17
- Registration Number
- NCT01662921
- Locations
- 🇺🇸
William Sansum Diabetes Center, Santa Barbara, California, United States
A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants
- Conditions
- Interventions
- First Posted Date
- 2012-07-11
- Last Posted Date
- 2014-06-16
- Lead Sponsor
- Adocia
- Target Recruit Count
- 37
- Registration Number
- NCT01638325
- Locations
- 🇸🇬
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore, Singapore
Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease
- Conditions
- Locations
- 🇺🇸
LSUHSC Shrevport Psychopharmacology Research Clinic, Shreveport, Louisiana, United States
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
- Conditions
- Interventions
- First Posted Date
- 2012-06-18
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 577
- Registration Number
- NCT01621178
- Locations
- 🇺🇸
Academic Medical Research Institute, Los Angeles, California, United States
🇺🇸Extended Arm Physician, Inc., Montgomery, Alabama, United States
🇺🇸Infosphere, West Hills, California, United States
Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes
- Conditions
- Interventions
- First Posted Date
- 2012-06-07
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- Sansum Diabetes Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT01613807
Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase
- Conditions
- Interventions
- First Posted Date
- 2012-02-06
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- Halozyme Therapeutics
- Target Recruit Count
- 25
- Registration Number
- NCT01526733
- Locations
- 🇺🇸
Profil Institute for Clinical Research, Chula Vista, California, United States
A Study in Participants With Type 1 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 455
- Registration Number
- NCT01481779
- Locations
- 🇷🇺
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Saint Petersburg, Russian Federation
Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
- Conditions
- Interventions
- First Posted Date
- 2011-11-18
- Last Posted Date
- 2014-03-20
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 122
- Registration Number
- NCT01474538
- Locations
- 🇺🇸
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Salt Lake City, Utah, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.